ORBA Wealth Advisors L.L.C. Acquires 37 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ORBA Wealth Advisors L.L.C. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,482 shares of the healthcare conglomerate’s stock after buying an additional 37 shares during the period. ORBA Wealth Advisors L.L.C.’s holdings in UnitedHealth Group were worth $2,036,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Bornite Capital Management LP bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $15,794,000. Bell Investment Advisors Inc raised its holdings in UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 24 shares during the last quarter. Baird Financial Group Inc. boosted its stake in shares of UnitedHealth Group by 71.0% in the 4th quarter. Baird Financial Group Inc. now owns 476,586 shares of the healthcare conglomerate’s stock valued at $250,909,000 after purchasing an additional 197,834 shares during the last quarter. Bradley Foster & Sargent Inc. CT raised its stake in UnitedHealth Group by 7.3% during the fourth quarter. Bradley Foster & Sargent Inc. CT now owns 149,535 shares of the healthcare conglomerate’s stock worth $78,726,000 after buying an additional 10,212 shares during the last quarter. Finally, Harbert Fund Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth about $1,316,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $2.75 on Friday, hitting $600.45. 393,009 shares of the stock were exchanged, compared to its average volume of 3,913,443. The firm has a market capitalization of $554.47 billion, a PE ratio of 39.63, a P/E/G ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $583.48 and its two-hundred day moving average is $530.04.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the previous year, the firm posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is 55.70%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. UBS Group increased their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Argus lifted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Royal Bank of Canada boosted their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, TD Cowen boosted their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $617.37.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.